A new hemoglobin variant found during Hb A1c measurement: Hb Hokusetsu [beta52(D3)Asp-->Gly]. 1998

T Nakanishi, and A Miyazaki, and M Kishikawa, and A Shimizu, and O Kishida, and S Sumi, and T Tsubakio, and K Imai
Department of Clinical Pathology, Osaka Medical College, Takatsuki, Japan.

A new beta chain variant was accidentally found through the assay of Hb A1c in a diabetic patient. The variant was detected by polyacrylamide gel isoelectrofocusing and electrospray ionization mass spectrometry. For sequence determination, globin was cleaved with combination of trypsin and lysyl endopeptidase and analyzed by high performance liquid chromatography connected to electrospray ionization mass spectrometry. An abnormal betaT-5 peptide was found by reconstructed selected ion monitoring. The collision-induced dissociation spectrum of an ion derived from the abnormal betaT-5 peptide revealed a new substitution, [beta52(D3)Asp-->Gly], named Hb Hokusetsu. The sequence was confirmed with an automatic sequencer using peptides isolated by reversed phase high performance liquid chromatography. Amplification of the beta-globin exon 2 and nucleotide sequencing revealed a GAT-->GGT mutation in codon 52 corresponding to an Asp-->Gly replacement. Electrospray ionization mass spectrometry analysis of the hemolysate showed a reasonable value of 10.4% for glycated globin. The variant migrated as Hb S on isoelectrofocusing. Hematological analysis revealed normal parameters. The patient's hemolysate showed normal stability in the isopropanol test. Oxygen equilibrium studies on the patient's red blood cells and hemolysate showed no significant change in oxygen affinity or cooperativity.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006455 Hemoglobins, Abnormal Hemoglobins characterized by structural alterations within the molecule. The alteration can be either absence, addition or substitution of one or more amino acids in the globin part of the molecule at selected positions in the polypeptide chains. Abnormal Hemoglobins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

T Nakanishi, and A Miyazaki, and M Kishikawa, and A Shimizu, and O Kishida, and S Sumi, and T Tsubakio, and K Imai
June 2008, Annals of hematology,
T Nakanishi, and A Miyazaki, and M Kishikawa, and A Shimizu, and O Kishida, and S Sumi, and T Tsubakio, and K Imai
March 2020, Hemoglobin,
T Nakanishi, and A Miyazaki, and M Kishikawa, and A Shimizu, and O Kishida, and S Sumi, and T Tsubakio, and K Imai
January 1986, Hemoglobin,
T Nakanishi, and A Miyazaki, and M Kishikawa, and A Shimizu, and O Kishida, and S Sumi, and T Tsubakio, and K Imai
March 2022, Hemoglobin,
T Nakanishi, and A Miyazaki, and M Kishikawa, and A Shimizu, and O Kishida, and S Sumi, and T Tsubakio, and K Imai
January 1987, Hemoglobin,
T Nakanishi, and A Miyazaki, and M Kishikawa, and A Shimizu, and O Kishida, and S Sumi, and T Tsubakio, and K Imai
February 2004, Hemoglobin,
T Nakanishi, and A Miyazaki, and M Kishikawa, and A Shimizu, and O Kishida, and S Sumi, and T Tsubakio, and K Imai
July 2021, Hemoglobin,
T Nakanishi, and A Miyazaki, and M Kishikawa, and A Shimizu, and O Kishida, and S Sumi, and T Tsubakio, and K Imai
January 1987, Hemoglobin,
T Nakanishi, and A Miyazaki, and M Kishikawa, and A Shimizu, and O Kishida, and S Sumi, and T Tsubakio, and K Imai
January 1987, Hemoglobin,
T Nakanishi, and A Miyazaki, and M Kishikawa, and A Shimizu, and O Kishida, and S Sumi, and T Tsubakio, and K Imai
January 1992, Hemoglobin,
Copied contents to your clipboard!